These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1778087)

  • 21. Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers.
    Klausner EA; Lavy E; Stepensky D; Cserepes E; Barta M; Friedman M; Hoffman A
    J Clin Pharmacol; 2003 Jul; 43(7):711-20. PubMed ID: 12856384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, open-label, 5-way crossover study to evaluate the pharmacokinetic/pharmacodynamic interaction between furosemide and the non-steroidal anti-inflammatory drugs diclofenac and ibuprofen in healthy volunteers.
    Paterson CA; Jacobs D; Rasmussen S; Youngberg SP; McGuinness N
    Int J Clin Pharmacol Ther; 2011 Aug; 49(8):477-90. PubMed ID: 21781648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incurred sample reanalysis: different evaluation approaches on data obtained for spironolactone and its active metabolite canrenone.
    Voicu V; Gheorghe MC; Sora ID; Sârbu C; Medvedovici A
    Bioanalysis; 2011 Jun; 3(12):1343-56. PubMed ID: 21679029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A bioequivalence study of two products of furosemide tablets.
    Awad R; Arafat T; Saket M; Saleh M; Gharaibeh M; Zmeili S; Sallam E; Shubair M; Qobrosi S
    Int J Clin Pharmacol Ther Toxicol; 1992 Jan; 30(1):18-23. PubMed ID: 1551740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of lisinopril on urinary electrolytes excretion after furosemide in healthy subjects.
    Sudoh T; Fujimura A; Shiga T; Tateishi T; Sunaga K; Ohashi K; Ebihara A
    J Clin Pharmacol; 1993 Jul; 33(7):640-3. PubMed ID: 8396158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The pharmacodynamic and pharmacokinetic characteristics of furosemide and furesis].
    Noskov VB; Goncharov IB; Kovachevich IV; Kodratenko SN; Starodubtsev AK; Sokolova EV
    Eksp Klin Farmakol; 1999; 62(3):32-6. PubMed ID: 10439945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of meloxicam on furosemide pharmacokinetics and pharmacodynamics in healthy volunteers.
    Müller FO; Schall R; de Vaal AC; Groenewoud G; Hundt HK; Middle MV
    Eur J Clin Pharmacol; 1995; 48(3-4):247-51. PubMed ID: 7589049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of saluretics and spironolactone on aldosterone production and electrolyte excretion in man.
    Erbler HC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(2):145-56. PubMed ID: 4281879
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacokinetic studies and bioavailability of bendroflumethiazide in combination with spironolactone].
    Vergin H; Nuss U; Strobel K
    Arzneimittelforschung; 1986 Mar; 36(3):490-5. PubMed ID: 3707669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites.
    Sungaila I; Bartle WR; Walker SE; DeAngelis C; Uetrecht J; Pappas C; Vidins E
    Gastroenterology; 1992 May; 102(5):1680-5. PubMed ID: 1568578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into the pharmacokinetics of spironolactone.
    Overdiek HW; Hermens WA; Merkus FW
    Clin Pharmacol Ther; 1985 Oct; 38(4):469-74. PubMed ID: 4042530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of long-acting furosemide and instant-acting amiloride: pharmacokinetics and pharmacodynamics in human subjects.
    Flouvat B; Roux A; Leneveu A; Prinseau J; Alexandre JA
    Fundam Clin Pharmacol; 1991; 5(8):741-52. PubMed ID: 1783363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone.
    Hsueh TP; Tsai TH
    BMC Complement Med Ther; 2020 Aug; 20(1):253. PubMed ID: 32799863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successive ratio subtraction as a novel manipulation of ratio spectra for quantitative determination of a mixture of furosemide, spironolactone and canrenone.
    Emam AA; Abdelaleem EA; Naguib IA; Abdallah FF; Ali NW
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Mar; 192():427-436. PubMed ID: 29202387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics and pharmacokinetics of furosemide-retard and furosemide-retard/triamterene.
    Heimsoth V; Loew D; Schuster O
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):161-4. PubMed ID: 3240762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study.
    Cho SH; Lim HS; Ghim JL; Choe S; Kim UJ; Jung JA; Bae KS
    Clin Ther; 2009 May; 31(5):1046-53. PubMed ID: 19539105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function.
    Traeger A; Stein G; Sperschneider H; Keil E
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):481-6. PubMed ID: 6500766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis.
    Alván G; Beermann B; Hjelte L; Lind M; Lindholm A; Strandvik B
    Clin Pharmacol Ther; 1988 Oct; 44(4):436-41. PubMed ID: 3168395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
    Lesne M
    Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.